Akèy › Kansè renn
Etid klinik pou Kansè renn ap rekrite nan Etazini
59 etid pou Kansè renn ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY15 etid
- Nashville, TN12 etid
- Boston, MA12 etid
- Houston, TX10 etid
- San Diego, CA9 etid
- Dallas, TX9 etid
- Washington, DC9 etid
- St. Louis, MO9 etid
- Edison, NJ8 etid
- Seattle, WA8 etid
- Rochester, MN7 etid
- Baltimore, MD7 etid
- Jacksonville, FL7 etid
- Miami, FL7 etid
- Los Angeles, CA7 etid
- Mountain View, CA6 etid
- Omaha, NE6 etid
- Durham, NC6 etid
- Aurora, CO6 etid
- Baldwin Park, CA6 etid
- Queens, NY6 etid
- Phoenix, AZ5 etid
- Pittsburgh, PA5 etid
- Cleveland, OH5 etid
- Columbus, OH5 etid
- New Rochelle, NY5 etid
- Staten Island, NY5 etid
- New Haven, CT4 etid
- Atlanta, GA4 etid
- Portland, OR4 etid
- Louisville, KY4 etid
- Highlands Ranch, CO4 etid
- Detroit, MI4 etid
- San Francisco, CA4 etid
- Orange, CA4 etid
- Denver, CO4 etid
- East Norwalk, CT4 etid
- San Antonio, TX4 etid
- Sacramento, CA3 etid
- Orlando, FL3 etid
Pa eta
- Arizona8 etid
- Arkansas3 etid
- Colorado9 etid
- Connecticut6 etid
- Florid14 etid
- Georgia6 etid
- Illinois7 etid
- Indiana4 etid
- Iowa4 etid
- Kalifòni19 etid
- Kentucky4 etid
- Lwizyàn3 etid
- Maryland16 etid
- Massachusetts14 etid
- Michigan6 etid
- Minnesota10 etid
- Missouri10 etid
- Nebraska6 etid
- New Jersey8 etid
- New York17 etid
- North Carolina8 etid
- Ohio10 etid
- Oklahoma4 etid
- Oregon4 etid
- Pennsylvania10 etid
- South Carolina5 etid
- Tennessee12 etid
- Texas18 etid
- Virginia6 etid
- Washington8 etid
- Wisconsin6 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT00050752Distance-Based Exercise to Preserve Function and Prevent Disability
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07059884Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
4 Weeks · Tout sèks · Mizajou Oct 2, 2026 · NCT01109394[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
Ap rekriteFaz 1
Laj 18 a 120 · Tout sèks · Mizajou Oct 2, 2026 · NCT06479811A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06234605Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05287945Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT00026884Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07011719Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT00033137Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT04981119A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07401875NSAID Use After Robotic Partial Nephrectomy
Ap rekriteFaz 2
Laj 18 a 99 · Tout sèks · Mizajou Sep 24, 2026 · NCT05842044Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 18, 2026 · NCT06948552Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 18, 2026 · NCT07828704A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07688187Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07227415Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06138067A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT05536141Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT00001238A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT07123090A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT07195682Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT07300241Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT05433142A Study of a Side Effects and Resource Navigation Program for People With Cancer
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07646847Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)
Ap rekriteFaz 1/2
Laj 18 a 100 · Tout sèks · Mizajou Jul 29, 2026 · NCT05665361Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.